First, emails have this week been swishing around the bioethics scholarly community, quoting an alleged letter from Summer Johnson McGee announcing her resignation as editor in chief of the American Journal of Bioethics, as well as stepping out of the connected website business Bioethics.net. In both instances effective from September 14.

Second, William Heisel posted about and commented on this news and how it was viewed by remaining editor in chief, David Magnus on his blog at Reporting on Health, where he also quoted the above mentioned letter. The spirit of the post was that, possibly, perhaps as an add-on to the former troubles, Johnson McGee's unfortunate apparent connection to a number of recently announced and rather grave conflict of interest declaration problems at AJOB linked to an ongoing federal investigation of research corruption with pharma money at the former academic home of both AJOB, Bioethics.net and Johnson McGee may have become too much to handle.

On twitter, people are asking Heisel about what's going on with no response so far – his account is silent since September 11, when he posted info about an update to the mentioned blog post. I was in contact with him via email the day before yesterday, but he did only want to talk on the phone about this matter and since we are 9 hours apart timezone-wise, this has not yet been possible to arrange. Or he has decided it wise not to communicate on the matter at this point.

Given the past occurrences of lawsuit threats in response to blog posts or articles connecting to AJOB and the businesses of its (now former) editorial management (see my last post on AJOB for more on that), it's not without that one is getting a bit worried. At the same time, if it really is true that Summer Johnson McGee is stepping down in the way indicated by all the rumors and signs, doing it in a cloud of civil law action would hardly make the whole thing more graceful, so I cross my fingers for her sake as well as Heisel's.

Hopefully, not least for AJOB's sake, all of these question marks will be straightened out soon. But, let's play with the thought that the initial rumor is true – what would that imply for AJOB? This, to my mind, depends on two things. First, Johnson McGee's actual connection to the recent round of problems around conflict of interest declarations and the linked alleged pharma corrupted research on pain medication. If this alleged link is weak or non-existent, Johnson McGee stepping down would not seem to help restoring confidence in AJOB through that route. Second, the point that I raised in my latest post on this topic about the problem of having an editor in chief that is directly financially dependent on what pieces are published in AJOB, through how that affects Bioethics.net traffic and advertisement revenue. This aspect of AJOB integrity is not fixed by Johnson McGee stepping down, since it remains to be known how the ownership of Bioethics.net looks from September 15, and how Bioethics.net will be connected to the AJOB operation in the future. Transparency on these points is absolutely crucial for AJOB's reputation, and something should ideally be posted about this in the about section at Bioethics.net and/or the journal website at the publisher as soon as possible.

I can also report that the original web-cache link to Heisel's blog post was killed by Google (possibly on the request by someone of the involved parties), and has now been replaced by another service.